Bacillary Dysentery (Shigella)

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Bacillary Dysentery (Shigella) is an infection that affects the large intestine, causing inflammation and damage to the bowel lining. It is caused by bacteria called Shigella, which spread through contaminated food, water, or close contact with an infected person. The main symptoms include bloody diarrhea, abdominal pain, and fever. This condition can lead to dehydration due to frequent loose stools. It primarily affects the digestive system and can cause significant discomfort and illness, especially in young children and the elderly. Prompt diagnosis and treatment are important to manage symptoms and prevent complications.

Clinical Definition

Bacillary Dysentery (Shigella) is an acute infectious colitis caused by invasive Shigella species, primarily S. dysenteriae, S. flexneri, S. boydii, and S. sonnei. The pathogenesis involves bacterial invasion of the colonic mucosa, leading to mucosal ulceration, intense inflammatory response, and bloody, mucoid diarrhea. The infection is transmitted via the fecal-oral route and is highly contagious. Clinically, it presents with fever, abdominal cramps, tenesmus, and dysentery characterized by frequent passage of small-volume stools containing blood and mucus. The disease is significant due to its potential for causing severe dehydration, systemic toxicity, and complications such as hemolytic uremic syndrome in certain strains. Diagnosis and management are critical to reduce morbidity and prevent outbreaks.

Inciting Event

  • Ingestion of contaminated food or water containing Shigella bacteria

  • Direct fecal-oral spread, including sexual exposure, is efficient because only a very small inoculum is needed.

  • Outbreaks in crowded settings such as daycare centers or refugee camps

Latency Period

  • 1 to 7 days from exposure to symptom onset, typically 1-3 days

Diagnostic Delay

  • Initial misattribution to viral gastroenteritis due to overlapping symptoms

  • Lack of stool culture or delayed stool testing for Shigella species

  • Mild or atypical presentations leading to under-recognition

  • Empiric treatment without microbiologic confirmation

Clinical Presentation


Signs & Symptoms

  • Small-volume bloody or mucoid stools with tenesmus define dysentery; Shigella infection can also cause watery diarrhea without visible blood.

  • Abdominal cramps and pain are common due to colonic inflammation.

  • Fever and malaise often accompany the gastrointestinal symptoms.

  • Tenesmus or painful straining during defecation is characteristic.

  • Nausea and vomiting may occur but are less prominent.

History of Present Illness

  • Acute onset of high fever and abdominal cramps followed by diarrhea

  • Progression to bloody, mucoid stools with tenesmus and urgency

  • Associated symptoms include nausea, vomiting, and malaise

  • Symptoms typically last 5-7 days but can persist longer

Past Medical History

  • Previous episodes of gastrointestinal infections may increase suspicion

  • History of immunosuppression or malnutrition can worsen disease severity

  • Recent travel to endemic areas or contact with infected individuals

Family History

  • This is an acquired infection, not an inherited disorder. Household contacts may share exposure or acquire infection from one another.

Physical Exam Findings

  • Abdominal tenderness localized to the lower quadrants is common in bacillary dysentery.

  • Signs of dehydration such as dry mucous membranes and decreased skin turgor may be present.

  • Fever is often observed during the acute phase of infection.

  • Tenesmus is a reported persistent urge or painful straining to defecate; observing it during a rectal examination is not required.

  • Blood and mucus in stool can sometimes be seen on digital rectal exam.

Diagnostic Workup


Diagnostic Criteria

Test stool by culture or a molecular panel. Obtain culture after a positive culture-independent result, especially for susceptibility and outbreak work. Some panels report Shigella/EIEC together. Fecal leukocytes indicate inflammation but cannot establish the cause.

Pathophysiology


Key Mechanisms

  • After crossing through M cells, Shigella invades colonic epithelium and spreads between cells using IcsA-mediated actin polymerization, producing mucosal inflammation and ulceration.

  • Shiga toxin, classically from S. dysenteriae type 1, removes an adenine from 28S rRNA in the 60S ribosomal subunit, inhibiting host protein synthesis. It is not produced by every Shigella strain.

  • Neutrophil recruitment causing intense inflammatory response and tissue destruction

  • Disruption of water and electrolyte absorption resulting in diarrhea and dehydration

InvolvementDetails
Organs

Colon is the main organ affected, where Shigella invades epithelial cells causing inflammation, ulceration, and dysentery symptoms.

Tissues

Colonic mucosa is the primary site of Shigella invasion and ulceration, leading to characteristic bloody diarrhea.

Cells

Neutrophils are recruited to the colonic mucosa and mediate tissue damage and pus formation in bacillary dysentery.

Shigella can trigger inflammatory macrophage pyroptosis, releasing mediators such as IL-1 and facilitating tissue invasion.

Colonic epithelial cells are invaded and destroyed by Shigella, leading to mucosal ulceration and bloody diarrhea.

Chemical Mediators

Interleukin-1 (IL-1) is released by infected macrophages, promoting inflammation and fever in bacillary dysentery.

Tumor necrosis factor-alpha (TNF-α) amplifies the inflammatory response causing mucosal injury and systemic symptoms.

Prostaglandins contribute to increased intestinal secretion and motility, worsening diarrhea.

Treatments


Pharmacological Treatments

  • Ciprofloxacin

    • Mechanism:
      • Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication in Shigella.

    • Side effects:
      • Tendon rupture

      • Gastrointestinal upset

      • Photosensitivity

    • Clinical role:
      • Oral option when antibiotics are indicated and the isolate is susceptible; resistance is common. Severe illness, immune impairment or transmission concerns may justify treatment; mild illness often needs hydration alone.

  • Azithromycin

    • Mechanism:
      • Binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis in Shigella.

    • Side effects:
      • Gastrointestinal upset

      • QT prolongation

      • Hepatotoxicity

    • Clinical role:
      • Oral option selected using susceptibility and local resistance. Ceftriaxone is another option for appropriate cases; suspected extensively resistant disease requires specialist input rather than an automatic standard regimen.

  • Trimethoprim-sulfamethoxazole

    • Mechanism:
      • Inhibits sequential steps in bacterial folate synthesis, impairing DNA synthesis in Shigella.

    • Side effects:
      • Rash

      • Bone marrow suppression

      • Hyperkalemia

    • Clinical role:
      • Use only when susceptibility is documented; widespread resistance makes routine empiric use unreliable.

Non-pharmacological Treatments

  • Oral rehydration is central; severe dehydration or inability to drink may require IV fluids. Many mild infections recover without antibiotics.

  • Implement strict hand hygiene and sanitation measures to reduce transmission of Shigella.

  • Avoid antimotility drugs, such as loperamide, in shigellosis because they can worsen illness.

Prevention


Pharmacological Prevention

  • No widely available vaccine currently exists for Shigella; antibiotic prophylaxis is not routinely recommended.

  • Do not routinely give preventive antibiotics to asymptomatic contacts. Evaluate symptomatic contacts and follow public-health instructions during outbreaks.

Non-pharmacological Prevention

  • Hand hygiene with soap and water is critical to prevent fecal-oral transmission.

  • Safe drinking water and proper sanitation reduce infection risk.

  • Food safety measures including thorough cooking and avoiding contaminated food.

  • Stay out of childcare/school while diarrheal and follow local return-to-work rules for food handlers and healthcare workers; avoid food preparation for others while ill.

  • Address sexual transmission: CDC dedicated prevention guidance advises avoiding sex until at least 2 weeks after diarrhea ends, with hygiene/barriers afterward because shedding can persist.

Outcome & Complications


Complications

  • Toxin-producing strains, especially S. dysenteriae type 1, can cause HUS: microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury.

  • Severe dehydration from profuse diarrhea can lead to hypovolemic shock.

  • Sepsis may develop in immunocompromised or severely ill patients.

  • Rectal prolapse can occur in young children with severe dysentery.

  • Reactive arthritis may develop as a post-infectious complication.

Short-term Sequelae Long-term Sequelae
  • Persistent diarrhea lasting beyond the acute phase may occur.

  • Electrolyte imbalances such as hypokalemia due to fluid loss.

  • Perianal irritation and ulceration from frequent stools.

  • Seizures can occur in children, often with fever or metabolic disturbances; the mechanism is not fully explained.

  • Post-infectious irritable bowel syndrome (IBS) can develop after resolution.

  • Persistent bloody diarrhea or ongoing colitis requires reassessment for continuing infection, inflammatory bowel disease or another cause; do not assume routine post-Shigella mucosal scarring.

  • Growth retardation in children due to repeated or severe infections.

  • Reactive arthritis may persist for months after infection.

Differential Diagnoses


Bacillary Dysentery (Shigella) versus Enterohemorrhagic Escherichia coli (EHEC) infection

Bacillary Dysentery (Shigella)

Enterohemorrhagic Escherichia coli (EHEC) infection

Infection with Shigella species invading colonic mucosa

Shiga-toxin-producing E. coli, including O157:H7 and non-O157 strains; epithelial attachment and toxin injury rather than Shigella-type invasion.

Bloody diarrhea with high fever and abdominal cramps

Often causes bloody diarrhea without high fever

Positive stool culture for Shigella species

Test for Shiga toxin/toxin genes and culture for O157 as appropriate. Avoid antibiotics and antimotility agents when STEC is suspected or confirmed because of HUS risk.

Bacillary Dysentery (Shigella) versus Campylobacter jejuni infection

Bacillary Dysentery (Shigella)

Campylobacter jejuni infection

Infection with Shigella, a non-motile gram-negative rod

Infection with Campylobacter jejuni, a curved gram-negative rod

Often associated with fecal-oral transmission from contaminated water or food

Often associated with undercooked poultry or unpasteurized milk

Bloody diarrhea with prominent tenesmus and high fever

Diarrhea may be watery or bloody, often preceded by fever and malaise

Bacillary Dysentery (Shigella) versus Clostridioides difficile colitis

Bacillary Dysentery (Shigella)

Clostridioides difficile colitis

Fecal-oral infection can occur with or without prior antibiotics.

Recent antibiotics or healthcare exposure increase risk, but community-associated infection can occur without either.

Bloody diarrhea with mucus and severe abdominal cramps

Profuse watery diarrhea, often without blood

Positive stool culture or PCR for Shigella species

Compatible diarrhea with an appropriate toxin/NAAT testing algorithm. A molecular positive alone can reflect colonization; toxin assays have imperfect sensitivity.

Bacillary Dysentery (Shigella) versus Amebic dysentery (Entamoeba histolytica infection)

Bacillary Dysentery (Shigella)

Amebic dysentery (Entamoeba histolytica infection)

Infection with gram-negative bacterial Shigella species

Infection with protozoan parasite Entamoeba histolytica

Acute onset with mucosal ulceration and bloody diarrhea

May be acute or more indolent; colonic flask-shaped ulcers and possible liver abscess are characteristic, but neither is required.

Positive stool culture or PCR for Shigella species

Use E. histolytica-specific stool PCR or antigen testing; microscopy alone cannot reliably separate pathogenic E. histolytica from E. dispar.

Bacillary Dysentery (Shigella) versus Salmonella enterocolitis

Bacillary Dysentery (Shigella)

Salmonella enterocolitis

Infection with non-motile Shigella species

Infection with motile Salmonella species

Fecal-oral transmission from contaminated water or food

Often linked to contaminated poultry, eggs, or reptiles

Often fever and tenesmus with dysentery, but severity varies.

Watery or bloody diarrhea with variable fever; fever intensity alone does not distinguish Salmonella from Shigella.